{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:45:11Z","timestamp":1789598711823,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T00:00:00Z","timestamp":1372204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00467-013-2538-0","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T21:24:10Z","timestamp":1372195450000},"page":"2125-2130","source":"Crossref","is-referenced-by-count":25,"title":["Seroprotection for hepatitis B in children with nephrotic syndrome"],"prefix":"10.1007","volume":"28","author":[{"given":"Mukta","family":"Mantan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagaraj","family":"Pandharikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan Rai","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,26]]},"reference":[{"key":"2538_CR1","first-page":"13","volume":"122","author":"A Bagga","year":"2005","unstructured":"Bagga A, Mantan M (2005) Nephrotic syndrome in children. Indian J Med Res 122:13\u201328","journal-title":"Indian J Med Res"},{"key":"2538_CR2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639","journal-title":"Lancet"},{"key":"2538_CR3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00467-011-1851-8","volume":"26","author":"L Bakkali","year":"2011","unstructured":"Bakkali L, Pereira RR, Kuik D, Ket JCR, Wijk J (2011) Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol 26:1241\u20131246","journal-title":"Pediatr Nephrol"},{"key":"2538_CR4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","volume":"17","author":"MJ Kemper","year":"2002","unstructured":"Kemper MJ, Altrogge H, Gansehow R, Wiefel DE (2002) Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol 17:413\u2013417","journal-title":"Pediatr Nephrol"},{"key":"2538_CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3349\/ymj.2010.51.2.239","volume":"51","author":"JW Han","year":"2010","unstructured":"Han JW, Lee KY, Hwang JY, Koh DK, Lee J (2010) Antibody status in children with steroid-sensitive nephrotic syndrome. Yonsei Med J 51:239\u2013243","journal-title":"Yonsei Med J"},{"key":"2538_CR6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00878360","volume":"6","author":"A Manna La","year":"1992","unstructured":"La Manna A, Polito C, Foglia AC, Di Toro A, Cafaro MR, Del Gado R (1992) Reduced response to hepatitis B virus vaccination in boys with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 6:251\u2013253","journal-title":"Pediatr Nephrol"},{"key":"2538_CR7","first-page":"25","volume":"70","author":"P Grzesiowski","year":"1995","unstructured":"Grzesiowski P, Ta\u0144ska A, Sieniawska M (1995) The influence of hepatitis B vaccine dose on direct results of hepatitis B vaccination in children with nephrotic syndrome. Pediatr Pol 70:25\u201328","journal-title":"Pediatr Pol"},{"key":"2538_CR8","first-page":"402","volume":"58","author":"I Szajner-Milart","year":"2003","unstructured":"Szajner-Milart I, Zajaczkowska M, Zinkiewicz Z, Borzecka H, Majewski M (2003) Efficacy of vaccination against viral hepatitis type B in children with the nephrotic syndrome. Ann Univ Mariae Curie Sklodowska Med 58:402\u2013408","journal-title":"Ann Univ Mariae Curie Sklodowska Med"},{"key":"2538_CR9","first-page":"663","volume":"44","author":"A Batham","year":"2007","unstructured":"Batham A, Narula D, Toteja T, Sreenivas V, Puliyel J (2007) Systematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatrics 44:663\u2013674","journal-title":"Indian Pediatrics"},{"key":"2538_CR10","first-page":"18","volume":"22","author":"B Ahmad","year":"2001","unstructured":"Ahmad B, Grover R, Ratho RK, Mahajan RC (2001) Prevalence of hepatitis B virus infection in Chandigarh over a six year period. Trop Gastroenterol 22:18\u201319","journal-title":"Trop Gastroenterol"},{"key":"2538_CR11","first-page":"299","volume-title":"Vaccines","author":"E Mast","year":"2004","unstructured":"Mast E, Mahoney FJ, Kane M, Margolis H (2004) Hepatitis B vaccine. In: Plotkin SA, Orenstein WA (eds) Vaccines, 4th edn. W.B. Saunders, Philadelphia, pp 299\u2013337","edition":"4"},{"key":"2538_CR12","unstructured":"Centers for Disease Control and Prevention (1993) Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 42 (No. RR-4)"},{"key":"2538_CR13","unstructured":"[No authors listed] (1981) The primary nephrotic syndrome in children: Identification of patients with minimal change nephrotic syndrome from initial response to prednisolone. A report of the International Study of Kidney Disease in Children J Pediatr 98:56\u2013564"},{"key":"2538_CR14","doi-asserted-by":"crossref","unstructured":"European Consensus Group on Hepatitis B immunity (2000) Are booster immunizations needed for lifelong hepatitis B immunity? Lancet 355:561\u2013565","DOI":"10.1016\/S0140-6736(99)07239-6"},{"key":"2538_CR15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","volume":"14","author":"DJ West","year":"1996","unstructured":"West DJ, Calandra GB (1996) Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14:1019\u20131027","journal-title":"Vaccine."},{"key":"2538_CR16","first-page":"265","volume":"45","author":"B Baytan","year":"2008","unstructured":"Baytan B, Gunes AM, Gunay U (2008) Efficacy of primary hepatitis B immunization in children with acute lymphoblastic leukemia. Indian Pediatr 45:265\u2013270","journal-title":"Indian Pediatr"},{"key":"2538_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(81)91847-X","volume":"317","author":"J Crosnier","year":"1981","unstructured":"Crosnier J, Jungers P, Courouce AM, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P (1981) Randomized placebo-controlled trial of hepatitis B surface antigen vaccine in French hemodialysis units. I Medical staff. Lancet 317:455\u2013459","journal-title":"Lancet"},{"key":"2538_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199201000-00007","volume":"14","author":"M Bruguera","year":"1992","unstructured":"Bruguera M, Cremades M, Salinas R, Costa J, Grau M, Sans J (1992) Impaired response to recombinant hepatitis B vaccine in HIV infected persons. J Clin Gastroenterol 14:27\u201330","journal-title":"J. Clin. Gastroenterol"},{"key":"2538_CR19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1086\/314578","volume":"179","author":"AD Jack","year":"1999","unstructured":"Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC (1999) What level of hepatitis B antibody is protective? J Infect Dis 179:489\u2013492","journal-title":"J Infect Dis"},{"key":"2538_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","volume":"78","author":"JN Zuckerman","year":"2006","unstructured":"Zuckerman JN (2006) Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 78:169\u2013177","journal-title":"J Med Virol"},{"key":"2538_CR21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.healun.2005.07.015","volume":"25","author":"WQ Foster","year":"2006","unstructured":"Foster WQ, Murphy A, Vega DJ, Smith AL, Hott BJ, Book WM (2006) Hepatitis B vaccination in heart transplant candidates. J Heart Lung Transplant 25:106\u2013109","journal-title":"J Heart Lung Transplant."}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2538-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2538-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2538-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T09:14:01Z","timestamp":1563268441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2538-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,26]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2538"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2538-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,26]]}}}